Valuation: AstraZeneca PLC

Market Cap 24TCr 3,71,42800Cr 22TCr 20TCr 18TCr 35TCr 23,45800Cr 35TCr 2,44600Cr 95TCr 11,97300Cr 91TCr 89TCr 38,48400Cr P/E 2026 *
20x
P/E 2027 * 17.5x
Enterprise Value 26TCr 4,01,70000Cr 24TCr 22TCr 20TCr 38TCr 25,37000Cr 38TCr 2,64500Cr 1,02900Cr 12,94800Cr 99TCr 97TCr 41,62100Cr EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.81x
Free-Float
96.62%
Yield 2026 *
2.13%
Yield 2027 * 2.26%
1 day-0.74%
1 week-5.53%
Current month-2.64%
1 month-1.36%
3 months-20.41%
6 months-14.64%
Current year-9.74%
1 week 63,600
Extreme 63600
67,200
1 month 61,000
Extreme 61000
68,000
Current year 60,650
Extreme 60650
80,275
1 year 54,750
Extreme 54750
80,275
3 years 24,288
Extreme 24288
80,275
5 years 5,438.5
Extreme 5438.5
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-5.53% - - 24TCr
+0.02%-3.52%+35.27%+111.11% 1,01900Cr
-1.21%-6.99%+34.42%+60.96% 62TCr
+1.12%-0.20%+15.45%+80.24% 46TCr
-3.30%-6.15%+57.14%+34.69% 36TCr
+0.93%-3.16%+21.65%+43.02% 33TCr
+0.12%-2.77%+10.70%+32.97% 27TCr
-0.89%-6.28%-7.00%+8.01% 24TCr
-0.01%-3.62%+37.01%+52.02% 22TCr
-0.08%-4.98%+27.34%+93.61% 18TCr
Average -0.61%-3.54%+25.78%+57.40% 41.08TCr
Weighted average by Cap. -0.41%-3.54%+28.68%+68.60%

Financials

2026 *2027 *
Net sales 6.32TCr 96,32400Cr 5.64TCr 5.25TCr 4.78TCr 9TCr 6,08300Cr 9.06TCr 63TCr 25TCr 3,10500Cr 24TCr 23TCr 9,98000Cr 6.7TCr 1,02,23000Cr 5.98TCr 5.57TCr 5.07TCr 9.55TCr 6,45600Cr 9.62TCr 67TCr 26TCr 3,29500Cr 25TCr 25TCr 10,59200Cr
Net income 1.2TCr 18,35500Cr 1.07TCr 1TCr 910.39Cr 1.71TCr 1,15900Cr 1.73TCr 12TCr 4.7TCr 59TCr 4.52TCr 4.42TCr 1,90200Cr 1.38TCr 21,00700Cr 1.23TCr 1.14TCr 1.04TCr 1.96TCr 1,32700Cr 1.98TCr 14TCr 5.38TCr 68TCr 5.17TCr 5.06TCr 2,17700Cr
Net Debt 1.99TCr 30,27200Cr 1.77TCr 1.65TCr 1.5TCr 2.83TCr 1,91200Cr 2.85TCr 20TCr 7.76TCr 98TCr 7.45TCr 7.29TCr 3,13700Cr 1.21TCr 18,42400Cr 1.08TCr 1TCr 913.81Cr 1.72TCr 1,16400Cr 1.73TCr 12TCr 4.72TCr 59TCr 4.54TCr 4.44TCr 1,90900Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
02/26/02 ARS 63,675.00 -0.74% 621
01/26/01 ARS 64,150.00 -1.91% 85
30/26/30 ARS 65,400.00 -1.32% 113
29/26/29 ARS 66,275.00 -1.45% 161
28/26/28 ARS 67,250.00 -0.22% 358
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
157.04USD
Average target price
209.82USD
Spread / Average Target
+33.61%

Quarterly revenue - Rate of surprise